FindTrial
Sign In

A Phase 1 Study of PRT12396 in Participants with Select Myeloproliferative Neoplasms

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-525484-40-00
Enrollment
12
Registered
2026-07-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-risk Polycythemia Vera, Intermediate-1, Intermediate-2, or High-Risk Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, Post-Polycythemia Vera Myelofibrosis

Interventions

None listed

Sponsors

Prelude Therapeutics Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Jul 30, 2026